WonderTx YCアプリケーション

Summer 2026Active

San Francisco

WonderTxはSummer 2026バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Summer 2026
業界: HealthcareTherapeutics
所在地: San Francisco
チーム規模: 3
ステータス: Active
ローンチ済み: 2026

創業者

Abraham HeifetsFounder/CEO

WonderTxの事業内容

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

WonderTxのYCアプリケーション、再構築済み

Y Combinator 申請

WonderTx 様、Summer 2026 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

WonderTx

Describe what your company does in 50 characters or less.

AI discovers pills to replace injectable drugs

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-native biotech platform for oral drug discovery. Our tech designs new molecules that let you take, for example, insulin or Ozempic as a pill instead of a shot. Our models are trained to reason on targets that have worked in real humans, not just in animal models, removing the main risk in drug discovery. Drug discovery teams use our molecules to pursue first-in-class oral drugs for validated biology where there was no tractable starting point before.

Where do you live now, and where would the company be based after YC?

We are based in San Francisco, CA, USA, and work remotely. After YC, we will remain based in San Francisco and remote.

Explain your decision regarding location.

San Francisco has a deep biotech and AI ecosystem, which helps on both the research and fundraising side. Our work is computational and experimental, so we work distributed, but physically close to the Bay Area network.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

WonderTxの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、WonderTxの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。WonderTxのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。